We are very happy that CymaBay Therapeutics chose to present the convincing data from their study in the NIF mouse. They nicely show that Seladelpar, which is a substance in clinical studies, reduces fibrosis in the NIF mouse in both liver and kidney. You will find the PDF of the poster "Seladelpar reduces established liver [...]
About wpadminThis author has not yet filled in any details.
So far wpadmin has created 62 blog entries.
We are happy and proud that our NIF mouse is the model used in the preclinical poster presented by Cymabay Therapeutics at the upcoming AASLD meeting, with the title "Seladelpar reduces established liver and renal fibrosis in the non-obese diabetic inflammation and fibrosis (NIF) mouse model"Take a look at the press release here!
InfiCure Bio attended the EASL NAFLD Summit in September, and presented this poster with up-to-date data on the NIF mouse.
Lena Söderström, Head of board at InfiCureBio, will share her views on listing of companies. Take the opportunity to listen to her experiences!
Inficure Bio will attend the EASLE NAFLD Summit, and present a poster on the NIF mouse. Don't miss the opportunity to take part of the latest updates on how to use the NIF mouse for preclinical testing of new NASH drugs. Take a look at the poster "The NIF mouse – a unique way to [...]
Present and former members of InfiCure Bio rounded up before summer holidays with a lunch in the sun in central Umeås beautiful park. We now look forward to a relaxing holiday and will return with lots of energy and new ideas in August!
Don't miss the presentation by Sofia Mayans at the virtual 4th Global NASH Congress, April 28 at 12.45, where she will share the latest discoveries on our unique NIF liver model!
Make sure to book a one-on-one meeting with Dan Holmberg and/or Sofia Mayans, and take the opportunity to discuss the most recent data on the NIF mouse and learn how the model can help in the development of anti-inflammatory and/or anti-fibrotic drugs.
Dan Holmberg, CSO at InfiCure Bio, will participate at the 3rd Annual Chronic Kidney Disease (CKD) Summit March 2-4, hosted by Hanson Wade. Make sure to take the opportunity to meet with Dan, and learn more about our unique NIF mouse- a spontaneous liver and kidney fibrosis model!
Sofia Mayans, CEO at InfiCure Bio, will participate in the national pitching competition "Hela Sverige Pitchar" by Connect Sverige. InfiCure Bio is one of 5 companies in Life Science/MedTech that will pitch on January 29 for Connects network of investors, the largest in Sweden.